As­traZeneca to in­vest $90 mn in In­dia

India Business Journal - - NEWS ROUND-UP -

As­traZeneca will in­vest $90 mil­lion (around Rs 590 crore) in

In­dia over the next five years. The in­vest­ment by the phar­ma­ceu­ti­cal com­pany is a part of a bi­lat­eral in­no­va­tion part­ner­ship signed be­tween Swe­den and In­dia for a sus­tain­able fu­ture. Ac­cord­ing to As­traZeneca, this in­vest­ment com­mit­ment across its busi­ness foot­print in In­dia will make a pos­i­tive im­pact. It will also align closely with the govern­ment's vi­sion for health­care and in­no­va­tion. The in­vest­ment com­mit­ment will be aimed at strength­en­ing man­u­fac­tur­ing, clin­i­cal op­er­a­tions, pa­tient safety and reg­u­la­tory sci­ence, IT ser­vices and com­mer­cial op­er­a­tions.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.